Sign in
NBY Stock Price, Chart, Stats & News
NovaBay Pharmaceuticals, Inc.
Save
NovaBay Pharmaceuticals, Inc. (NBY) is a dividend-paying stock with a current dividend yield of 314.96% as of May 29, 2026. It pays $4.00 per share over the trailing twelve months and distributes annually.
NBY chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | – |
ROA | -245.06% |
ROE | 821.56% |
D/E | -0.03x |
Interest coverage ratio | – |
NBY valuation
P/E | – |
P/S | – |
P/B | -0.38x |
P/CF | -1.04x |
P/FCF | -4.76x |
P/OCF | -1.04x |
PEG | 0.00x |
EV multiple | -6.33x |
About
NovaBay Pharmaceuticals, Inc. (NBY) is a pharmaceutical company that specializes in developing and globally distributing products for eyecare and dermatology. Its product portfolio includes Avenova, an advanced solution designed for cleaning the delicate skin around the eye, such as the eyelids, by removing foreign substances, microorganisms, and debris. The company also offers wound management solutions under its NeutroPhase and PhaseOne brands.
Related lists
Similar securities
Based on sector and market capitalization
Report issue